Journal Article

Targeted Next-Generation Sequencing Reveals Divergent Clonal Evolution in Components of Composite Pleomorphic Xanthoastrocytoma-Ganglioglioma

Devine, Patrick, Tihan, Tarik, Pekmezci, Melike, Solomon, David A, Ramani, Biswarathan, Raleigh, David R, Hervey-Jumper, Shawn L, Mirchia, Kanish, Goldschmidt, Ezequiel, Lucas, Calixto-Hope G, Alashari, Mouied, Gupta, Nalin, Bruggers, Carol S, Oberheim Bush, Nancy Ann, Perry, Arie, Cadwell, Cathryn R, Cheshier, Samuel H, Sullivan, Daniel V, Davidson, Christian J, Whipple, Nicholas S, Mendez, Joe S, Lu, Rufei, Walker, Jeffrey B, Van Ziffle, Jessica, Bollen, Andrew, Phillips, Joanna J, Putnam, Angelica R

2022

Overview

Abstract Composite pleomorphic xanthoastrocytoma-ganglioglioma (PXA-GG) is an extremely rare central nervous system neoplasm with 2 distinct but intermingled components. Whether this tumor represents a “collision tumor” of separate neoplasms or a monoclonal neoplasm with divergent evolution is poorly understood. Clinicopathologic studies and capture-based next generation sequencing were performed on extracted DNA from all available PXA-GG at 2 medical centers. Five PXA-GG were diagnosed in 1 male and 4 female patients ranging from 13 to 25 years in age. Four arose within the cerebral hemispheres; 1 presented in the cerebellar vermis. DNA was sufficient for analysis in 4 PXA components and 3 GG components. Four paired PXA and GG components harbored BRAF p.V600E hotspot mutations. The 4 sequenced PXA components demonstrated CDKN2A homozygous deletion by sequencing with loss of p16 (protein product of CDKN2A) expression by immunohistochemistry, which was intact in all assessed GG components. The PXA components also demonstrated more frequent copy number alterations relative to paired GG components. In one PXA-GG, shared chromosomal copy number alterations were identified in both components. Our findings support divergent evolution of the PXA and GG components from a common BRAF p.V600E-mutant precursor lesion, with additional acquisition of CDKN2A homozygous deletion in the PXA component as is typically seen in conventional PXA.

• Publisher: Oxford University Press
• Subject: Adolescent / Adult / Astrocytoma / Astrocytoma - genetics / Astrocytoma - pathology / Brain Neoplasms - genetics / Brain Neoplasms - pathology / Care and treatment / Clonal Evolution / Cyclin-Dependent Kinase Inhibitor p16 - genetics / Diagnosis / DNA / DNA sequencing / Evolution / Female / Ganglioglioma - pathology / Genetic aspects / Genetic research / Health aspects / High-Throughput Nucleotide Sequencing / Homozygote / Humans / Immunohistochemistry / Male / Morphological variation / Mutation - genetics / Nucleotide sequencing / Original / Proto-Oncogene Proteins B-raf - genetics / Sequence Deletion / Tumors / Young Adult